August 9, 2018

Lawmakers’ Stock Holdings Show Lack of Limits on Their Trading

Five GOP House members in January 2017 bought shares of an Australian biotechnology company that’s at the center of an insider trading indictment of Rep. Chris Collins (R-N.Y.), congressional financial disclosures show.

Collins, who represents a district in western New York, is the only lawmaker accused by prosecutors of wrongdoing—stemming from his role on Innate Immunotherapeutics Ltd.’s board, not his position in the House.

Read the source article at Big Law Business

Additional Articles You May Like

Sign Up To Receive Our Free Newsletter